Physician Photo

Philip Crawford Amrein, MD

  • Phone: 617-724-3456
Department of Medicine


  • Cancer Center
  • Leukemia
  • Hematology
Clinical Interests
Acute leukemia
Chronic leukemia
Myeloproliferative neoplasms
Boston: Massachusetts General Hospital
Medical Education
MD, Johns Hopkins University School of Medicine
Residency, Waterbury Hospital Health Center
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Patient Age Group
Accepting New Patients
Accepting New Patients

Publications1) Schiffer CA,...Amrein PC,..."A double-blind, placebo-controlled trial of pegylated recombinant MGDF as an adjunct to induction and consolidation therapy to patients with acute myeloid leukemia". Blood 2000;95:2530-2535.
2) Moore JO,...Amrein PC,...."Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: CALGB study 9222". Blood 2005;105:3420-3427.
3) Attar EC,...Amrein PC. "Phase I and pharmacokinetic  study of bortezomib in combination with idarubicin and cytarabine in patients with AML".  Clinical Cancer Research 2008;14:1446-1454.
4) DeAngelo D,...Amrein PC,..."A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphocytic leukemia". Blood (ASH abstract #580) 2007.
5) Amrein PC, et al. "Dasatinib has activity in relapsed/refractory CLL/SLL". Blood (ASH abstract #3162) 2008.

Hematology/Oncology BMT Program
100 Blossom Street
Boston, MA 02114-2606

Phone: 617-724-3456
Phone 2: 617-726-8748
Fax: 617-643-1915